Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Li X, Chen W, Liu K, et al. Cancer Manag Res. 2020;12:8081–8091 The authors have advised Figure 5D and 5E (on page 8088) is incorrect due to layout negligence during figure disposal. The correct Figure is shown below. Read the original article
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-03-01
|
| Series: | Cancer Management and Research |
| Online Access: | https://www.dovepress.com/corrigendum-oridonin-sensitizes-hepatocellular-carcinoma-to-the-antica-peer-reviewed-article-CMAR |